Stock Scorecard
Stock Summary for Exelixis Inc (EXEL) - $44.69 as of 4/30/2026 11:56:27 AM EST
Total Score
13 out of 30
Safety Score
41 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for EXEL
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for EXEL
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for EXEL
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for EXEL
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for EXEL (41 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 6 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for EXEL
Financial Details for EXEL
Company Overview |
|
|---|---|
| Ticker | EXEL |
| Company Name | Exelixis Inc |
| Country | N/A |
| Description | Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development, and commercialization of new drugs to treat cancers in the United States. The company is headquartered in Alameda, California. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 12/31/2025 |
| Next Earnings Date | 5/5/2026 |
Stock Price History |
|
| Last Day Price | 44.69 |
| Price 4 Years Ago | 16.04 |
| Last Day Price Updated | 4/30/2026 11:56:27 AM EST |
| Last Day Volume | 1,857,471 |
| Average Daily Volume | 2,454,031 |
| 52-Week High | 49.62 |
| 52-Week Low | 33.76 |
| Last Price to 52 Week Low | 32.38% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 34.44 |
| Sector PE | 85.51 |
| 5-Year Average PE | 18.39 |
| Free Cash Flow Ratio | 23.52 |
| Industry Free Cash Flow Ratio | 23.13 |
| Sector Free Cash Flow Ratio | 26.30 |
| Current Ratio Most Recent Quarter | 3.56 |
| Total Cash Per Share | 1.90 |
| Book Value Per Share Most Recent Quarter | 8.23 |
| Price to Book Ratio | 5.28 |
| Industry Price to Book Ratio | 6.60 |
| Sector Price to Book Ratio | 5.71 |
| Price to Sales Ratio Twelve Trailing Months | 4.89 |
| Industry Price to Sales Ratio Twelve Trailing Months | 9.60 |
| Sector Price to Sales Ratio Twelve Trailing Months | 27.97 |
| Analyst Buy Ratings | 9 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 254,008,000 |
| Market Capitalization | 11,351,617,520 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 2.47% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 84.20% |
| Annual Earnings Growth | 50.13% |
| Reported EPS 12 Trailing Months | 2.78 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | 3.12 |
| Net Income Twelve Trailing Months | 782,570,000 |
| Net Income Past Year | 782,570,000 |
| Net Income Prior Year | 521,267,000 |
| Quarterly Revenue Growth YOY | 5.60% |
| 5-Year Revenue Growth | 18.63% |
| Operating Margin Twelve Trailing Months | 39.40% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 482,488,000 |
| Total Cash Past Year | 482,488,000 |
| Total Cash Prior Year | 217,374,000 |
| Net Cash Position Most Recent Quarter | 482,488,000 |
| Net Cash Position Past Year | 482,488,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 2,161,319,000 |
| Total Stockholder Equity Prior Year | 2,244,203,000 |
| Total Stockholder Equity Most Recent Quarter | 2,161,319,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 855,588,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 3.37 |
| Free Cash Flow Past Year | 844,339,000 |
| Free Cash Flow Prior Year | 633,786,000 |
Options |
|
| Put/Call Ratio | 0.16 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.82 |
| MACD Signal | 0.75 |
| 20-Day Bollinger Lower Band | 40.81 |
| 20-Day Bollinger Middle Band | 43.57 |
| 20-Day Bollinger Upper Band | 46.34 |
| Beta | 0.42 |
| RSI | 52.86 |
| 50-Day SMA | 42.08 |
| 150-Day SMA | 31.50 |
| 200-Day SMA | 28.13 |
System |
|
| Modified | 5/1/2026 10:26:04 PM EST |